| European Case Law Identifier: | ECLI:EP:BA:1996:T076793.19961113 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 13 November 1996 | ||||||||
| Case number: | T 0767/93 | ||||||||
| Application number: | 87302001.0 | ||||||||
| IPC class: | C12N 15/38 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines, and recombinant vectors therefor | ||||||||
| Applicant name: | Cogent Limited | ||||||||
| Opponent name: | SmithKline Beecham Biologicals SA | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Entitlement to priority Main request - novelty (yes) Inventive step (no) - subject-matter of independent claim obvious First auxiliary request - inventive step (yes) Disclosure - sufficiency (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t930767eu1.html
Date retrieved: 17 May 2021